Indaptus Therapeutics, Inc.
USD3.05
-0.01 (-0.39%)
CEO
Junyi Dai
IPO Date
2015-08-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.41
Prev. Close
$3.06
Day Low
$2.97
Day High
$3.41
52W Low
$0.92
52W High
$13.40
Market Cap
$0.01B
Volume
0.03M
| -14.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -127.7% | -103.3% | 0.01 | 5.05 | -26.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -58.2% | -51.0% | 0.00 | 7.94 | -23.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -21.5% | -19.0% | 0.00 | 8.77 | -84.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 1507.8% | -201.6% | 0.00 | 0.86 | -582.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -412.6% | -223.7% | 0.12 | 1.65 | -9.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -81.3% | -70.8% | 0.00 | 5.69 | -151.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -49.2% | -44.8% | 0.00 | 9.80 | -88.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -58.9% | -54.1% | 0.00 | 10.77 | -136.7 |
| -0.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -64.6% | -43.5% | 0.00 | 2.88 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 312.5% | -76.5% | -3.91 | 0.75 | -2.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -161.9% | -83.8% | 0.02 | 1.90 | -7.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -104.7% | -56.3% | 0.02 | 1.95 | -13.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -51.1% | -37.2% | 0.02 | 3.42 | -26.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -65.1% | -49.4% | 0.02 | 3.88 | -32.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -40.7% | -34.8% | 0.02 | 6.70 | -35.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -33.1% | -26.8% | 0.01 | 5.05 | -25.9 |